This section is an incomplete list of mainly commercial companies but also other entities, namely governmental institutions and individual persons, actively involved in research towards finding a cure to diabetes type 1.
It does not list research funds, hospitals in which research is undertaken, etc., but only the industrious, actual developers of such products.
Entities are listed alphabetically along with their status of research in that field, so that also entities which ceased research into finding a cure to diabetes type 1 may be listed.
- Amylin Pharmaceuticals – is working toward finding a cure, and has a drug on the market called Symlin (pramlintide acetate) that helps in treating type 1 diabetes
- Cerco Medical – Present status: Unknown
- Denise Faustman [http://www.massgeneral.org/diabetes/faculty_faustman.htm – Present status: Working on immune modification
- DeveloGen – Present status: Developing DiaPep 277
- Diamyd Medical [http://www.diamyd.com – Present status: Developing GAD65-based vaccine (phase III trial started)
- Tolerx - Present status: Now (4/2009) in Phase 3 clinical study of otelixizumab, an Fc-disabled, anti-CD3 monoclonal antibody in patients with new onset (diagnosis within last 10 weeks) type 1 diabetes.
- National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases http://t1dstudy.niddk.nih.gov/about.html
Further Reading
This article is licensed under the Creative Commons Attribution-ShareAlike License.
It uses material from the Wikipedia article on
"Diabetes mellitus type 1"
All material adapted used from Wikipedia is available under the terms of the
Creative Commons Attribution-ShareAlike License.
Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.